- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06813716
Acute Effects of Two Neoprene Knee Sleeves
Comparison of the Acute Effects of Two Neoprene Knee Sleeves on Balance and Pain in Knee Osteoarthritis: A Randomized, Single-Blinded, Prospective Study
This study aimed to evaluate the immediate effects of two different types of elastic neoprene knee sleeves on balance and pain in patients with knee osteoarthritis (KOA). One knee sleeve was a standard elastic neoprene sleeve, while the other had four metal supports for additional stability.
In this randomized controlled study, 60 patients (50 females, 10 males) diagnosed with KOA were divided into two groups:
Group 1: Wore a standard elastic neoprene knee sleeve Group 2: Wore a neoprene knee sleeve with four metal supports
Each participant underwent clinical assessments before and after wearing the knee sleeve. The following tests were used:
Balance Assessments:
Berg Balance Scale (BBS): Measures overall balance ability. Timed Up and Go (TUG) Test: Evaluates mobility and fall risk. Functional Reach Test (FRT): Assesses stability by measuring how far a person can reach forward.
Fall Index (Tetrax® posturography): Provides an objective measure of fall risk.
Pain Assessment:
Visual Analog Scale (VAS): Measures the intensity of pain.
Further long-term studies are necessary to determine whether these immediate benefits persist over time.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Eskisehir, Turkey
- Eskişehir Osmangazi University Department of Physical Medicine and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Radiographic knee osteoarthritis grade 2 (mild) or 3 (moderate) according to Kellgren-Lawrence scale,
- Knee muscle strength of 4 and above and those who voluntarily participated in the study
- Signed the informed consent form
Exclusion Criteria:
- Patients with arthroscopy of the knee joint within the last 1 year, knee and/or hip replacement,
- Limitation of joint range of motion,
- History of inflammatory rheumatic disease,
- History of vestibular and cerebellar disease,
- Visual loss of less than 2/10 in both eyes,
- History of diseases of the central and peripheral nervous system (Parkinson's disease, stroke, ataxia, dementia, multiple sclerosis, peripheral neuropath etc.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group 1 : consisted of 30 patients wearing elastic neoprene knee sleeve
|
We hypothesized that a neoprene elastic knee sleeve with metal supports would have a greater acute effect on balance and pain than a neoprene elastic sleeve.
The first study to evaluate the acute effects of 2 different knee sleeves on pain and balance.
|
|
Active Comparator: group 2 consisted of 30 patients wearing neoprene knee sleeve with four metal supports
|
We hypothesized that a neoprene elastic knee sleeve with metal supports would have a greater acute effect on balance and pain than a neoprene elastic sleeve.
The first study to evaluate the acute effects of 2 different knee sleeves on pain and balance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Berg Balance Scale (BBS)
Time Frame: Assessments were performed before and immediately after wearing the knee sleeves
|
Total score is between 0-56.
56 points indicates perfect balance
|
Assessments were performed before and immediately after wearing the knee sleeves
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed Up and Go (TUG)
Time Frame: Assessments were performed before and immediately after wearing the knee sleeves
|
This test, which evaluates balance function is reported that a threshold value above 14 seconds predicts falls with high sensitivity and specificity.
|
Assessments were performed before and immediately after wearing the knee sleeves
|
|
Functional Reach Test (FRT)
Time Frame: Assessments were performed before and immediately after wearing the knee sleeves
|
15 cm or less indicates a significantly increased risk of falling, while 15 to 25 cm indicates a moderate risk of falling.
|
Assessments were performed before and immediately after wearing the knee sleeves
|
|
Fall Index, calculated using posturography (Tetrax®)
Time Frame: Assessments were performed before and immediately after wearing the knee sleeves
|
100 indicates the lowest risk of falling, while 0 indicates the highest risk of falling.
|
Assessments were performed before and immediately after wearing the knee sleeves
|
|
the Visual Analog Scale (VAS)
Time Frame: Assessments were performed before and immediately after wearing the knee sleeves
|
Patients were required to indicate the level of pain they were experiencing on a scale of 0 to 10, with 0 representing no pain and 10 representing the most intense pain they had ever felt.
|
Assessments were performed before and immediately after wearing the knee sleeves
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ESOGUFtr1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthristis
-
Foundation University IslamabadNot yet recruitingKnee OsteoarthristisPakistan
-
George Emil Palade University of Medicine, Pharmacy...Iuliu Hatieganu University of Medicine and Pharmacy; County Clinical Emergency...Recruiting
-
Technical University of MunichRecruitingKnee Osteoarthristis | Arthroplasty Replacement, KneeGermany
-
Lahore University of Biological and Applied SciencesNot yet recruiting
-
Mansoura UniversityCompletedKnee OsteoarthristisEgypt
-
Mahidol UniversityRecruitingArthroplasties, Knee Replacement | Knee OsteoarthristisChina
-
Maxx Orthopedics IncNot yet recruitingKnee Osteoarthristis | Total Knee AnthroplastyUnited States
-
Izmir Democracy UniversityRecruitingKnee OsteoarthristisTurkey (Türkiye)
-
MiKS HospitalRecruiting
-
Ludwig Boltzmann Institute for Digital Health and...Paracelsus Medical University; Medizinische Zentrum Bad Vigaun GmbH & Co. KGNot yet recruitingTotal Knee Replacement | Knee OsteoarthristisAustria
Clinical Trials on Neoprene elastic knee sleeve
-
Vicenç Punsola IzardCompletedProximal Interphalangeal Finger Joint ContracturesSpain
-
Vicenç Punsola IzardCompletedJoint Deformities, Acquired | Flexion Contracture of Proximal Interphalangeal JointSpain
-
Unity Health TorontoNot yet recruiting
-
University of SalfordNorthern Care Alliance NHS Foundation TrustUnknown
-
Memorial University of NewfoundlandNot yet recruitingOsteoarthritis of Knee | Sleeve Gastrectomy | Arthroplasties, Knee ReplacementCanada
-
University of Sao Paulo General HospitalCompletedKnee Osteoarthritis | Metabolic Disease
-
University of Alabama at BirminghamCompleted
-
Stanford UniversityCompleted
-
Sir Mortimer B. Davis - Jewish General HospitalCanadian Institutes of Health Research (CIHR); Sigvaris CorporationCompletedDeep Venous ThrombosisUnited States, Canada